HyperBio Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 41244909
Stærmosevej 12, 7120 Vejle Øst

Income statement (kDKK)

2020202120222023
Fiscal period length12121212
Net sales
Gross profit-5 571.12-12 881.90-8 628.93-74.48
Employee benefit expenses-40.00-60.00-55.00
EBIT-5 611.12-12 941.90-8 683.93-74.48
Other financial income6.967.0416.54155.20
Other financial expenses-27.35- 486.05-1 338.46-1 330.82
Pre-tax profit-5 631.52-13 420.91-10 005.85-1 250.10
Income taxes1 573.292 808.042 349.49277.36
Net earnings-4 058.23-10 612.87-7 656.37- 972.75

Assets (kDKK)

2020202120222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current amounts owed by group member comp.1 573.293 089.552 313.43277.36
Prepayments and accrued income3.28
Current other receivables39.8467.00135.6912.39
Short term receivables total1 616.403 156.542 449.12289.74
Cash and bank deposits10 419.6819 670.9613 222.6214 364.28
Cash and cash equivalents10 419.6819 670.9613 222.6214 364.28
Balance sheet total (assets)12 036.0822 827.5015 671.7414 654.03

Equity and liabilities (kDKK)

2020202120222023
Share capital40.0040.0040.0048.00
Retained earnings15 000.0015 941.775 328.901 664.53
Profit of the financial year-4 058.23-10 612.87-7 656.37- 972.75
Shareholders equity total10 981.775 368.90-2 287.47739.78
Non-current loans from credit institutions15 355.07
Non-current liabilities total15 355.07
Current loans from credit institutions0.990.57
Current trade creditors1 051.112 100.071 375.174.09
Current owed to group member16 583.4713 910.15
Other non-interest bearing current liabilities3.202.47
Current liabilities total1 054.312 103.5317 959.2113 914.24
Balance sheet total (liabilities)12 036.0822 827.5015 671.7414 654.03
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.